Form 4 for PTCT PTC THERAPEUTICS, INC.
Accepted 2025-10-07 00:00:00 ET · period of report 2025-10-03 · accession 0001680329-25-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-10-07 | 2025-10-03 | PTCT | Reeve Emma | Dir | S - Sale+OE | $65.96 | -25.6K | 12.7K | -67% | -$1.69M |
| DM | 2025-10-07 | 2025-10-03 | PTCT | Reeve Emma | Dir | M - OptEx | $35.73 | +25.6K | 20.3K | New | +$913.3K |
| DM | 2025-10-07 | 2025-10-03 | PTCT | Reeve Emma | Dir | M - OptEx | $0.00 | -25.6K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-03 | S | D | 1,600 | $66.93 | 10,332 | D | — | — | (F7) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $66.61 to $67.33 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2025-10-03 | M | A | 8,650 | $33.63 | 18,982 | D | — | — | |
| 3 | Common | Common Stock | 2025-10-03 | S | D | 2,729 | $65.05 | 16,253 | D | — | — | (F8) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $64.50 to $65.49 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 4 | Common | Common Stock | 2025-10-03 | S | D | 4,037 | $66.10 | 12,216 | D | — | — | (F9) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $65.50 to $66.46 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 5 | Common | Common Stock | 2025-10-03 | S | D | 1,884 | $66.89 | 10,332 | D | — | — | (F10) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $66.61 to $67.28 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 6 | Common | Common Stock | 2025-10-03 | M | A | 6,912 | $33.02 | 17,244 | D | — | — | |
| 7 | Common | Common Stock | 2025-10-03 | S | D | 2,163 | $65.02 | 15,081 | D | — | — | (F5) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $64.50 to $65.49 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 8 | Common | Common Stock | 2025-10-03 | S | D | 2,381 | $66.87 | 10,332 | D | — | — | (F4) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $66.50 to $67.29 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 9 | Common | Common Stock | 2025-10-03 | S | D | 3,149 | $66.11 | 11,932 | D | — | — | (F6) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $65.50 to $66.48 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 10 | Common | Common Stock | 2025-10-03 | M | A | 10,000 | $39.42 | 20,332 | D | — | — | |
| 11 | Common | Common Stock | 2025-10-03 | S | D | 3,028 | $65.09 | 17,304 | D | — | — | (F2) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $64.50 to $65.49 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 12 | Common | Common Stock | 2025-10-03 | S | D | 4,591 | $66.09 | 12,713 | D | — | — | (F3) This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $65.50 to $66.49 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 13 | Derivative | Stock Option (Right to Buy) | 2025-10-03 | M | D | 6,912 | $0.00 | 0 | D | $33.02 · — to 2029-01-21 | 6,912 Common Stock | (F11) Currently exercisable. |
| 14 | Derivative | Stock Option (Right to Buy) | 2025-10-03 | M | D | 8,650 | $0.00 | 0 | D | $33.63 · — to 2028-12-13 | 8,650 Common Stock | (F11) Currently exercisable. |
| 15 | Derivative | Stock Option (Right to Buy) | 2025-10-03 | M | D | 10,000 | $0.00 | 0 | D | $33.63 · — to 2033-01-04 | 10,000 Common Stock | (F11) Currently exercisable. |